The power of two — SLT and YAG

Whether you're treating glaucoma, or you're seeking to perform capsulotomy procedures, Tango™, with its fully featured SLT laser and its powerful, precise YAG laser, will ensure that you can achieve the results you and your patients are looking for — every time.

Related treatments

Related conditions

Related products

Main Image Landing Tango
Excellent results — every time
Excellent results — every time

Accuracy and efficacy

Tango’s dual-mode laser cavity allows you to move effortlessly between SLT and YAG modes, ensuring that you'll be able to treat patients across both modalities with maximum accuracy and optimal efficacy.

SLT… precision — and beyond 

Tango™ incorporates Ellex’s proprietary SLT technology — providing superior energy control, a sharp-edged aiming beam and the industry’s fastest firing rate of three shots per second. 

With an enhanced view of the trabecular meshwork, you'll be able to perform SLT procedures faster and more accurately. In addition, SLT is gentle and non-invasive, which means you can stimulate healthy trabecular meshwork cell regeneration and manage IOP without producing burn and scar tissue.

YAG… low energy, high efficiency

Tango’s YAG mode features an Ultra Gaussian beam profile and fast rise time. That enables you to perform capsulotomies and iridotomies at lower, more efficient energy levels.* With less energy delivered into the eye, you’ll be able to carry out capsulotomies with all types of IOLs and with significantly less risk of lens pitting.


*Based on system performance testing. Data on file. Ellex Medical.

Hotspots Tango1
A proprietary dual-mode laser cavity design allows you to efficiently switch between SLT and YAG modes at the touch of a button.
Hotspots Tango2
A highly accurate two-point focusing system with a tolerance range of ± 8 μm in YAG mode delivers pinpoint precision.

Contact us

*Not for complaints or regulatory bodies. View our Privacy Policy

Tango™ has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) (510k) Market release for the indications of Selective Laser Trabeculoplasty (SLT) Capsulotomy and Laser Iridotomy. , Posterior membranectomy 

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More

QUANTEL MEDICAL COMPLETES ACQUISITION OF ELLEX

Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.

The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.